Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Landry Kaucley"'
Autor:
Patrick G. Ilboudo, Téné-Alima Essoh, Roch A. Houngnihin, Daleb Abdoulaye Alfa, Naomi Dick, Landry Kaucley, Alexis Satoulou-Maleyo
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Little is known on the economic implications of multi-dose 13 valent pneumococcal conjugate vaccine (PCV13) introduction in expanded program on immunization (EPI). Based on evidence of PCV13’s reduced pressure on vaccine cold ch
Externí odkaz:
https://doaj.org/article/3ee47c99e7784fe6a34bf7032786ac5a
Autor:
Sètondji Géraud Roméo Padonou, Clément Kakaï Glèlè, Manfred Accrombessi, Bayode Romeo Adegbite, Edouard Dangbenon, Houssaïnatou Bah, Enangnon Akogbeto, Ali Imorou Bah Chabi, Landry Kaucley, Salifou Sourakatou, Ange Dossou, Achille Batonon, Tania Bissouma-Ledjou, Benjamin Hounkpatin
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1104 (2023)
Background: Having a maximum number of people vaccinated was the objective to control the COVID-19 pandemic. We report in this manuscript the factors associated with the willingness to be vaccinated against COVID-19 during the pandemic period. Method
Externí odkaz:
https://doaj.org/article/5f114a4e9f7a42f99595f0eb92f5c211
Autor:
Daleb Abdoulaye Alfa, Roch A. Houngnihin, G. Patrick Ilboudo, Naomi Dick, Landry Kaucley, Téné-Alima Essoh
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background In 2011, Benin introduced the 13-valent pneumococcal conjugated vaccine (PCV13), in a single-dose vial, into its Expanded Programme for Immunisation (EPI) with support from Gavi. In April 2018, with the support of the Agence de M
Externí odkaz:
https://doaj.org/article/6d12815dacc84ebba89fd61021c273c7
Autor:
Hounkpatin, Sètondji Padonou, Clément Kakaï Glèlè, Manfred Accrombessi, Bayode Adegbite, Edouard Dangbenon, Houssaïnatou Bah, Enangnon Akogbeto, Ali Bah Chabi, Landry Kaucley, Salifou Sourakatou, Ange Dossou, Achille Batonon, Tania Bissouma-Ledjou, Benjamin
Publikováno v:
Vaccines; Volume 11; Issue 6; Pages: 1104
Background: Having a maximum number of people vaccinated was the objective to control the COVID-19 pandemic. We report in this manuscript the factors associated with the willingness to be vaccinated against COVID-19 during the pandemic period. Method
Autor:
Olubukola T. Idoko, Iya Saidou Conde, Landry Kaucley, Esin Nkereuwem, Richard Banda, Oluwatosin O Nkereuwem, Sule Abdullahi, Joseph E Enegela, Tom Sesay, Richard Luce, Ngozi A Erondu, Anthony Afum-Adjei Awuah, Terna Nomhwange, Bassey Edem, Oghenebrume Wariri, Emmanuel Agogo, Beate Kampmann
Publikováno v:
Publons
The Lancet Global Health
The Lancet. Global Health
The Lancet Global Health
The Lancet. Global Health
Summary Background The WHO Regional Office for the Africa Regional Immunization Technical Advisory Group, in 2011, adopted the measles control and elimination goals for all countries of the African region to achieve in 2015 and 2020 respectively. Our
Autor:
Daleb Abdoulaye Alfa, Didier C. Agossadou, G. Patrick Ilboudo, Rock A. Houngnihin, Alexis Satoulou-Maleyo, Franck H. Bété, Modibo Dicko, Landry Kaucley, Téné-Alima Essoh
Publikováno v:
Vaccine. 38:6807-6813
Background Benin, a country eligible for Gavi support, changed the presentation of the 13-valent pneumococcal vaccine (PCV13) from the single-dose vial (SDV) to the multi-dose vial (MDV). The present work aims to evaluate the process of making this d
Autor:
Patrick G. Ilboudo, Téné-Alima Essoh, Roch A. Houngnihin, Daleb Abdoulaye Alfa, Naomi Dick, Landry Kaucley, Alexis Satoulou-Maleyo
Publikováno v:
BMC Public Health
BMC Public Health, Vol 22, Iss 1, Pp 1-10 (2022)
BMC Public Health, Vol 22, Iss 1, Pp 1-10 (2022)
Background Little is known on the economic implications of multi-dose 13 valent pneumococcal conjugate vaccine (PCV13) introduction in expanded program on immunization (EPI). Based on evidence of PCV13’s reduced pressure on vaccine cold chain, Beni
Autor:
Roch Houngnihin, Téné-Alima Essoh, G. Patrick Ilboudo, Daleb Abdoulaye Alfa, Landry Kaucley, Naomi Dick
Publikováno v:
BMC Public Health
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
BackgroundIn 2011, Benin introduced the 13-valent pneumococcal conjugated vaccine (PCV13), in a single-dose vial, into its Expanded Programme for Immunisation (EPI) with support from Gavi. In April 2018, with the support of the Agence de Médecine Pr
Autor:
Pierre Levy, Landry Kaucley
Publikováno v:
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation
Cost Effectiveness and Resource Allocation, 2015, 13, ⟨10.1186/s12962-015-0039-7⟩
Cost Effectiveness and Resource Allocation
Cost Effectiveness and Resource Allocation, 2015, 13, ⟨10.1186/s12962-015-0039-7⟩
Background This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Benin, a country heavily affecte